Bausch Health Companies Inc. Selling, General and Administrative Expense
Bausch Health Companies Inc. (BHC) reported Selling, General and Administrative Expense of $907.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-30
- Bausch Health Companies Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $907.00M, a 1.45% increase year-over-year.
- Bausch Health Companies Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $861.00M, a 0.69% decline year-over-year.
- Bausch Health Companies Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $882.00M, a 7.56% increase year-over-year.
- Bausch Health Companies Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $795.00M, a 6.47% decline year-over-year.
- Bausch Health Companies Inc. selling, general and administrative expense for fiscal 2025 was $3.44B, a 4.31% increase from fiscal 2024.
- Bausch Health Companies Inc. selling, general and administrative expense for fiscal 2024 was $3.30B, a 12.99% increase from fiscal 2023.
- Bausch Health Companies Inc. selling, general and administrative expense for fiscal 2023 was $2.92B, a 11.12% increase from fiscal 2022.
- Bausch Health Companies Inc. selling, general and administrative expense for fiscal 2022 was $2.63B, a 0.04% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $907.00M 10-Q · filed 2026-07-30 | $1.77B 10-Q · filed 2026-07-30 | $2.65B derived: sum of 3 quarters · filed 2026-07-30 | $3.44B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $861.00M 10-Q · filed 2026-04-30 | $1.74B derived: sum of 2 quarters · filed 2026-04-30 | $2.54B derived: sum of 3 quarters · filed 2026-04-30 | $3.43B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $882.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.68B derived: sum of 2 quarters · filed 2026-02-19 | $2.57B derived: sum of 3 quarters · filed 2026-07-30 | $3.44B 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $795.00M 10-Q · filed 2025-10-30 | $1.69B derived: sum of 2 quarters · filed 2026-07-30 | $2.56B 10-Q · filed 2025-10-30 | $3.38B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $894.00M 10-Q · filed 2026-07-30 | $1.76B 10-Q · filed 2026-07-30 | $2.58B derived: sum of 3 quarters · filed 2026-07-30 | $3.43B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $867.00M 10-Q · filed 2026-04-30 | $1.69B derived: sum of 2 quarters · filed 2026-04-30 | $2.54B derived: sum of 3 quarters · filed 2026-04-30 | $3.37B derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $820.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.67B derived: sum of 2 quarters · filed 2026-02-19 | $2.50B derived: sum of 3 quarters · filed 2026-02-19 | $3.30B 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $850.00M 10-Q · filed 2025-10-30 | $1.68B derived: sum of 2 quarters · filed 2025-10-30 | $2.48B 10-Q · filed 2025-10-30 | $3.24B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $832.00M 10-Q · filed 2025-07-31 | $1.63B 10-Q · filed 2025-07-31 | $2.39B derived: sum of 3 quarters · filed 2026-02-19 | $3.11B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $794.00M 10-Q · filed 2025-05-01 | $1.56B derived: sum of 2 quarters · filed 2026-02-19 | $2.27B derived: sum of 3 quarters · filed 2026-02-19 | $2.99B derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $766.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.48B derived: sum of 2 quarters · filed 2026-02-19 | $2.19B derived: sum of 3 quarters · filed 2026-02-19 | $2.92B 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $715.00M 10-Q · filed 2024-10-31 | $1.43B derived: sum of 2 quarters · filed 2024-10-31 | $2.15B 10-Q · filed 2024-10-31 | $2.82B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $711.00M 10-Q · filed 2024-08-01 | $1.44B 10-Q · filed 2024-08-01 | $2.10B derived: sum of 3 quarters · filed 2025-02-20 | $2.76B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $725.00M 10-Q · filed 2024-05-02 | $1.39B derived: sum of 2 quarters · filed 2025-02-20 | $2.05B derived: sum of 3 quarters · filed 2025-02-20 | $2.73B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $666.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.33B derived: sum of 2 quarters · filed 2025-02-20 | $2.00B derived: sum of 3 quarters · filed 2025-02-20 | $2.63B 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $661.00M 10-Q · filed 2023-11-02 | $1.34B derived: sum of 2 quarters · filed 2023-11-02 | $1.96B 10-Q · filed 2023-11-02 | $2.64B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $676.00M 10-Q · filed 2023-08-03 | $1.30B 10-Q · filed 2023-08-03 | $1.98B derived: sum of 3 quarters · filed 2024-02-22 | $2.63B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $622.00M 10-Q · filed 2023-05-04 | $1.30B derived: sum of 2 quarters · filed 2024-02-22 | $1.96B derived: sum of 3 quarters · filed 2024-02-22 | $2.64B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $680.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.33B derived: sum of 2 quarters · filed 2024-02-22 | $2.02B derived: sum of 3 quarters · filed 2024-02-22 | $2.62B 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $653.00M 10-Q · filed 2022-11-03 | $1.34B derived: sum of 2 quarters · filed 2022-11-03 | $1.94B 10-Q · filed 2022-11-03 | $2.58B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $685.00M 10-Q · filed 2022-08-09 | $1.29B 10-Q · filed 2022-08-09 | $1.93B derived: sum of 3 quarters · filed 2023-02-23 | $2.50B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $606.00M 10-Q · filed 2022-05-10 | $1.24B derived: sum of 2 quarters · filed 2023-02-23 | $1.81B derived: sum of 3 quarters · filed 2023-02-23 | $2.34B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $636.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.21B derived: sum of 2 quarters · filed 2023-02-23 | $1.73B derived: sum of 3 quarters · filed 2023-02-23 | $2.37B 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $572.00M 10-Q · filed 2021-11-02 | $1.10B derived: sum of 2 quarters · filed 2021-11-02 | $1.73B 10-Q · filed 2021-11-02 | $2.40B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $526.00M 10-Q · filed 2021-08-03 | $1.16B 10-Q · filed 2021-08-03 | $1.83B derived: sum of 3 quarters · filed 2022-05-11 | $2.48B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $633.00M 10-Q · filed 2021-05-04 | $1.30B derived: sum of 2 quarters · filed 2022-05-11 | $1.95B derived: sum of 3 quarters · filed 2022-05-11 | $2.60B derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $668.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $1.32B derived: sum of 2 quarters · filed 2022-05-11 | $1.97B derived: sum of 3 quarters · filed 2022-05-11 | $2.55B 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $648.00M 10-Q · filed 2020-11-03 | $1.30B derived: sum of 2 quarters · filed 2020-11-03 | $1.89B 10-Q · filed 2020-11-03 | $2.51B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $651.00M 10-Q · filed 2020-08-06 | $1.24B 10-Q · filed 2020-08-06 | $1.86B derived: sum of 3 quarters · filed 2021-05-04 | $2.48B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $587.00M 10-Q · filed 2020-05-07 | $1.21B derived: sum of 2 quarters · filed 2021-05-04 | $1.83B derived: sum of 3 quarters · filed 2021-05-04 | $2.47B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $626.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $1.24B derived: sum of 2 quarters · filed 2021-05-04 | $1.88B derived: sum of 3 quarters · filed 2021-05-04 | $2.47B 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $614.00M 10-Q · filed 2019-11-04 | $1.26B derived: sum of 2 quarters · filed 2019-11-04 | $1.85B 10-Q · filed 2019-11-04 | $2.49B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $642.00M 10-Q · filed 2019-08-06 | $1.23B 10-Q · filed 2019-08-06 | $1.87B derived: sum of 3 quarters · filed 2020-02-19 | $2.50B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $591.00M 10-Q · filed 2019-05-06 | $1.23B derived: sum of 2 quarters · filed 2020-02-19 | $1.85B derived: sum of 3 quarters · filed 2020-02-19 | $2.51B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $639.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.26B derived: sum of 2 quarters · filed 2020-02-19 | $1.92B derived: sum of 3 quarters · filed 2020-02-19 | $2.58B 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $623.00M 10-Q · filed 2018-11-06 | $1.28B derived: sum of 2 quarters · filed 2018-11-06 | $1.94B 10-Q · filed 2018-11-06 | $2.61B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $659.00M 10-Q · filed 2018-08-07 | $1.32B 10-Q · filed 2018-08-07 | $1.99B derived: sum of 3 quarters · filed 2019-02-20 | $2.65B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $661.00M 10-Q · filed 2018-05-08 | $1.33B derived: sum of 2 quarters · filed 2019-02-20 | $1.99B derived: sum of 3 quarters · filed 2019-02-20 | $2.66B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $665.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.33B derived: sum of 2 quarters · filed 2019-02-20 | $2.00B derived: sum of 3 quarters · filed 2019-02-20 | $2.81B 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $661.00M 10-Q · filed 2017-11-07 | $660.90M 10-Q · filed 2016-11-09 | $1.33B derived: sum of 2 quarters · filed 2017-11-07 | $2.15B 10-Q · filed 2017-11-07 | $2.89B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $671.00M 10-Q · filed 2017-08-08 | $671.50M 10-Q · filed 2016-08-09 | $1.48B 10-Q · filed 2017-08-08 | $1.48B 10-Q · filed 2016-08-09 | $2.23B derived: sum of 3 quarters · filed 2018-08-10 | $2.92B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-03-31 | $813.00M 10-Q · filed 2017-05-09 | $812.60M 10-Q · filed 2016-06-07 | $1.56B derived: sum of 2 quarters · filed 2018-08-10 | $2.25B derived: sum of 3 quarters · filed 2018-08-10 | $2.94B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $743.10M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $1.44B derived: sum of 2 quarters · filed 2018-08-10 | $2.13B derived: sum of 3 quarters · filed 2018-08-10 | $2.70B 8-K · filed 2018-08-10 | $2.70B 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $697.60M 10-Q · filed 2016-11-09 | $1.38B derived: sum of 2 quarters · filed 2016-11-09 | $1.96B 10-Q · filed 2016-11-09 | $2.48B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $685.50M 10-Q · filed 2016-08-09 | $1.26B 10-Q · filed 2016-08-09 | $1.78B derived: sum of 3 quarters · filed 2017-03-01 | $2.29B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $573.80M 10-Q · filed 2016-06-07 | $1.10B derived: sum of 2 quarters · filed 2017-03-01 | $1.60B derived: sum of 3 quarters · filed 2017-03-01 | $2.12B derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $524.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.03B derived: sum of 2 quarters · filed 2017-03-01 | $1.54B derived: sum of 3 quarters · filed 2017-03-01 | $2.03B 10-K · filed 2017-03-01 | $2.03B 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $504.10M 10-Q · filed 2015-10-26 | $1.02B derived: sum of 2 quarters · filed 2015-10-26 | $1.50B 10-Q · filed 2015-10-26 | $1.95B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $515.70M 10-Q · filed 2015-07-28 | $997.70M 10-Q · filed 2015-07-28 | $1.45B derived: sum of 3 quarters · filed 2016-04-29 | $1.80B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $482.00M 10-Q · filed 2015-04-30 | $932.30M derived: sum of 2 quarters · filed 2016-04-29 | $1.29B derived: sum of 3 quarters · filed 2016-04-29 | $1.55B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $450.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $806.00M derived: sum of 2 quarters · filed 2016-04-29 | $1.06B derived: sum of 3 quarters · filed 2016-04-29 | $1.31B 10-K · filed 2016-04-29 | $1.31B 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $355.70M 10-Q · filed 2014-10-24 | $355.64M 10-Q · filed 2013-11-01 | $613.00M derived: sum of 2 quarters · filed 2014-10-24 | $854.90M 10-Q · filed 2014-10-24 | $854.91M 10-Q · filed 2013-11-01 | $1.06B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $257.30M 10-Q · filed 2014-08-01 | $257.37M 10-Q · filed 2013-08-07 | $499.20M 10-Q · filed 2014-08-01 | $499.27M 10-Q · filed 2013-08-07 | $703.91M derived: sum of 3 quarters · filed 2015-02-25 | $892.57M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $241.90M 10-Q · filed 2014-05-09 | $241.90M 10-Q · filed 2013-05-03 | $446.61M derived: sum of 2 quarters · filed 2015-02-25 | $635.27M derived: sum of 3 quarters · filed 2015-02-25 | $820.71M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $204.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $393.37M derived: sum of 2 quarters · filed 2015-02-25 | $578.81M derived: sum of 3 quarters · filed 2015-02-25 | $756.10M 10-K · filed 2015-02-25 | $756.08M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $188.66M 10-Q · filed 2013-11-01 | $374.10M derived: sum of 2 quarters · filed 2013-11-01 | $551.39M 10-Q · filed 2013-11-01 | $699.89M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $185.44M 10-Q · filed 2013-08-07 | $362.73M 10-Q · filed 2013-08-07 | $511.23M derived: sum of 3 quarters · filed 2014-02-28 | $646.03M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $177.29M 10-Q · filed 2013-05-03 | $325.79M derived: sum of 2 quarters · filed 2014-02-28 | $460.60M derived: sum of 3 quarters · filed 2014-02-28 | $610.25M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $148.51M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $283.31M derived: sum of 2 quarters · filed 2014-02-28 | $432.97M derived: sum of 3 quarters · filed 2014-02-28 | $572.47M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $134.80M 10-Q · filed 2012-11-05 | $284.46M derived: sum of 2 quarters · filed 2012-11-05 | $423.96M 10-Q · filed 2012-11-05 | $551.72M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $149.66M 10-Q · filed 2012-08-03 | $289.16M 10-Q · filed 2012-08-03 | $416.92M derived: sum of 3 quarters · filed 2013-02-28 | $477.10M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $139.51M 10-Q · filed 2012-05-04 | $267.26M derived: sum of 2 quarters · filed 2013-02-28 | $327.44M derived: sum of 3 quarters · filed 2013-02-28 | $372.54M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $127.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $187.94M derived: sum of 2 quarters · filed 2013-02-28 | $233.03M derived: sum of 3 quarters · filed 2013-02-28 | $276.55M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $60.19M 10-Q · filed 2011-11-04 | $105.28M derived: sum of 2 quarters · filed 2011-11-04 | $148.79M 10-Q · filed 2011-11-04 | $178.91M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $45.09M 10-Q · filed 2011-08-08 | $88.61M 10-Q · filed 2011-08-08 | $118.72M derived: sum of 3 quarters · filed 2012-02-29 | $163.50M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $43.51M 10-Q · filed 2011-05-10 | $73.63M derived: sum of 2 quarters · filed 2012-02-29 | $118.40M derived: sum of 3 quarters · filed 2012-02-29 | $167.90M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $30.12M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $74.89M derived: sum of 2 quarters · filed 2012-02-29 | $124.39M derived: sum of 3 quarters · filed 2012-02-29 | $167.63M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $44.77M 10-Q · filed 2010-11-05 | $94.27M derived: sum of 2 quarters · filed 2010-11-05 | $137.52M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $49.50M 10-Q · filed 2010-08-06 | $92.74M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $188.92M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |